Apalutamide toxicity and tolerability: A real-world multicentre experience in metastatic hormone-sensitive prostate cancer (MHSPC) in the United Kingdom (UK).

被引：0
|
作者：
Ramamurthy, Sindhu
Elumalai, Thiraviyam
Pearson, Rachel
Bolnykh, Iakov
Muhammad-Afzal, Tehreem
Olukiran, Gbenro
Arora, Ananya
Bradley, Gay
Taft, Kate
Myint, Nayan Lin
Htike, Ei The
Ince, Will
Jiang, Xue Yan
机构：
[1] United Lincolnshire Hosp NHS Trust, Lincoln, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge, England
[3] Northern Ctr Canc Care, Newcastle Upon Tyne, Tyne & Wear, England
[4] United Lincolnshire Hosp NHS Trust, Grantham, England
[5] Univ Cambridge, Sch Med, Cambridge, England
[6] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-2494-5577-5578; 613-615-646-3281-7408-2638; 261-492-199; 130-3426-5390-2622; 130-3426-3529; 283-2494; 613-302-309; 6; 5; 4; 3; 2; 1917; 8;
D O I：
10.1200/JCO.2024.42.4_suppl.107
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer
    Azad, Arun A.
    Tran, Ben
    Davis, Ian D.
    Parente, Phillip
    Evans, Melanie
    Wong, Shirley
    Brown, Stephen
    Evans, Sue
    Millar, Jeremy
    Murphy, Declan G.
    Papa, Nathan
    INTERNAL MEDICINE JOURNAL, 2022, 52 (08) : 1339 - 1346
  • [32] Estimating median overall survival of apalutamide compared to placebo in metastatic hormone-sensitive prostate cancer (mHSPC) populations: Statistical extrapolations of the TITAN study
    Agarwal, Neeraj
    Bjartell, Anders
    Juarez, Alvaro
    Kerssenboom, Ronja
    Perualila, Nolen
    Wigfield, Peter
    Chi, Kim N.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 223 - 223
  • [33] Underutilization of androgen deprivation therapy (ADT) intensification for the treatment of men with metastatic hormone-sensitive prostate cancer (mHSPC): A systematic review of real-world database studies.
    Raval, Amit D.
    Chen, Stephanie
    Littleton, Natasha
    Constantinovici, Niculae
    Goebell, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 66 - 66
  • [34] Apalutamide for prostate cancer: Multicentre and multidisciplinary real-world study of 227 patients
    Sanchez, Julian Cordoba
    Picola, Natalia
    Rodriguez-Vida, Alejo
    Costa, Marc
    Castaneda, David Marmolejo
    Marquez, Meritxell Perez
    Rodriguez, Jesus Munoz
    Gaya, J. M.
    Bravo, Alejandra
    Buisan, Oscar
    Servian, Pol
    Suarez, Jose Francisco
    Felip, Mireia Musquera
    Caparros, Maria Jose Ribal
    Asensio, Antonio Alcaraz
    Vilaseca, Antoni
    CANCER MEDICINE, 2023, 12 (24): : 21969 - 21977
  • [35] Feasibility of cotargeting cell cycle and androgen signaling in metastatic hormone-sensitive prostate cancer (mHSPC).
    Palmbos, Phillip Lee
    Tomlins, Scott A.
    Agarwal, Neeraj
    Twardowski, Przemyslaw
    Morgans, Alicia Katherine
    Kelly, William Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [36] Real-world survival of men with metastatic hormone-sensitive prostate cancer (mHSPC) treated with abiraterone acetate (Abi) or docetaxel (Doc) and comparison with clinical trial outcomes.
    Geynisman, Daniel M.
    Correa, Andres F.
    Ramamurthy, Chethan
    Beck, Robert J.
    Handorf, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [37] ARASENS: A phase 3 trial of darolutamide in males with metastatic hormone-sensitive prostate cancer (mHSPC)
    Tombal, B.
    Saad, F.
    Hussain, M.
    Sternberg, C. N.
    Fizazi, K.
    Crawford, E. D.
    Yamada, K.
    Kappeler, C.
    Kuss, I.
    Smith, M. R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [38] Clinical outcomes in stratification subgroups in the ARASENS study in metastatic hormone-sensitive prostate cancer (mHSPC)
    Parnis, F.
    Tombal, B.
    Hussain, M.
    Saad, F.
    Fizazi, K.
    Sternberg, C. N.
    Crawford, E. D.
    Kopyltsov, E.
    Kalebasty, A. Rezazadeh
    Alekseev, B. Y.
    Montesa Pino, A.
    Ye, D.
    Melo Cruz, F. J. S.
    Tammela, T.
    Suzuki, H.
    Joensuu, H.
    Thiele, S.
    Li, R.
    Kuss, I.
    Smith, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S1501 - S1502
  • [39] Real-world experience of rucaparib in patients with ovarian cancer: A multicentre United Kingdom study
    Lythgoe, M.
    Cleary, S.
    Kalofonou, F.
    Grunewald, T.
    Miller, R.
    Cartwright, D.
    Glasspool, R. M.
    Jones, R.
    Rossides, S.
    Ratnakumaran, R.
    Michael, A.
    McNeish, I.
    Tookman, L.
    Krell, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S742 - S742
  • [40] Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database
    Eule, Corbin J.
    Kuna, Elizabeth Molina
    Robin, Tyler P.
    Gershman, Boris
    Flaig, Thomas W.
    Kim, Simon P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (12) : 447e17 - 447e24
12345